Advancing development of medical countermeasures: Incorporating COVID-19 lessons learned into future pandemic preparedness planning.
Autorzy:
Johnson RA; Department of Health and Human Services, Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, Washington, DC, USA. White RC; Department of Health and Human Services, Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, Washington, DC, USA.; Booz Allen Hamilton, McLean, VA, USA. DisbrowGL; Department of Health and Human Services, Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, Washington, DC, USA.
Pokaż więcej
Źródło:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Nov 30; Vol. 18 (6), pp. 2129930. Date of Electronic Publication: 2022 Oct 27.
Seasonal influenza vaccination is associated with reduced risk of death among Medicare beneficiaries .
Autorzy:
Buchman TG; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC, United States; Emory University, Atlanta, GA, United States. Electronic address: . Simpson SQ; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC, United States; University of Kansas, Kansas City, KS, United States. Sciarretta KL; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC, United States. Finne KP; Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC, United States. Sowers N; Acumen, LLC, Burlingame, CA, United States. Collier M; Acumen, LLC, Burlingame, CA, United States. Chavan S; Acumen, LLC, Burlingame, CA, United States. Do R; Acumen, LLC, Burlingame, CA, United States; Division of Cardiovascular Medicine, Department of Medicine, University of California, Irvine, CA, United States. Lin C; Acumen, LLC, Burlingame, CA, United States. Oke I; Acumen, LLC, Burlingame, CA, United States. Rhodes KE; Acumen, LLC, Burlingame, CA, United States. Santhosh A; Acumen, LLC, Burlingame, CA, United States. Sandhu AT; Acumen, LLC, Burlingame, CA, United States; Division of Cardiovascular Medicine, Department of Medicine, Stanford University, Stanford, CA, United States. Chu S; Center for Medicare and Medicaid Services, United States Department of Health and Human Services, Baltimore, MD, United States. Patel SA; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC, United States. DisbrowGL; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC, United States. Bright RA; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC, United States; Rockefeller Foundation, New York, NY, United States. MaCurdy TE; Acumen, LLC, Burlingame, CA, United States; Department of Economics, Stanford University, Stanford, CA, United States. Kelman JA; Center for Medicare and Medicaid Services, United States Department of Health and Human Services, Baltimore, MD, United States.
Pokaż więcej
Źródło:
Vaccine [Vaccine] 2021 Dec 20; Vol. 39 (52), pp. 7569-7577. Date of Electronic Publication: 2021 Nov 24.
Progress towards a vaccine against Ebola to meet emergency medical countermeasure needs.
Autorzy:
Wolfe DN; Health and Human Services (HHS)/Assistant Secretary for Preparedness and Response (ASPR)/Biomedical Advanced Research and Development Authority (BARDA), Thomas P. O'Neill Federal Building (FOB8), 200 C Street, SW, Washington, DC 20024, United States. Electronic address: . Zarrabian AG; Health and Human Services (HHS)/Assistant Secretary for Preparedness and Response (ASPR)/Biomedical Advanced Research and Development Authority (BARDA), Thomas P. O'Neill Federal Building (FOB8), 200 C Street, SW, Washington, DC 20024, United States. DisbrowGL; Health and Human Services (HHS)/Assistant Secretary for Preparedness and Response (ASPR)/Biomedical Advanced Research and Development Authority (BARDA), Thomas P. O'Neill Federal Building (FOB8), 200 C Street, SW, Washington, DC 20024, United States. Espeland EM; Health and Human Services (HHS)/Assistant Secretary for Preparedness and Response (ASPR)/Biomedical Advanced Research and Development Authority (BARDA), Thomas P. O'Neill Federal Building (FOB8), 200 C Street, SW, Washington, DC 20024, United States.
Pokaż więcej
Źródło:
Vaccine [Vaccine] 2019 Nov 15; Vol. 37 (48), pp. 7178-7182. Date of Electronic Publication: 2017 Dec 02.
Safeguarding against Ebola: Vaccines and therapeutics to be stockpiled for future outbreaks.
Autorzy:
Espeland EM; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), US Department of Health and Human Services (HHS), Washington, DC, United States of America. Tsai CW; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), US Department of Health and Human Services (HHS), Washington, DC, United States of America. Larsen J; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), US Department of Health and Human Services (HHS), Washington, DC, United States of America. DisbrowGL; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), US Department of Health and Human Services (HHS), Washington, DC, United States of America.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2018 Apr 05; Vol. 12 (4), pp. e0006275. Date of Electronic Publication: 2018 Apr 05 (Print Publication: 2018).
Are transforming properties of the bovine papillomavirus E5 protein shared by E5 from high-risk human papillomavirus type 16?
Autorzy:
Suprynowicz FA; Department of Pathology, Georgetown University Medical School, Preclinical Sciences Building, Room GR10C, 3900 Reservoir Road, NW, Box #571432, Washington, DC 20057, USA. DisbrowGL Simic V Schlegel R
Pokaż więcej
Źródło:
Virology [Virology] 2005 Feb 05; Vol. 332 (1), pp. 102-13.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, P.H.S.
Codon optimization of the HPV-16 E5 gene enhances protein expression.
Autorzy:
DisbrowGL; Department of Pathology, Georgetown University Medical School, Georgetown University Medical Center, Preclinical Science Building, Room GR10C, Washington, DC 20057, USA. Sunitha I Baker CC Hanover J Schlegel R
Pokaż więcej
Źródło:
Virology [Virology] 2003 Jun 20; Vol. 311 (1), pp. 105-14.
Typ publikacji:
Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies